Why we need to save our skins - Independent

While it is welcome news for cancer patients that the drug Ipilimumab has been approved for the treatment of Irish patients with malignant melanoma (Irish Independent, May 4), we need to take a lead from our Northern neighbours if we want to be truly ...

Immunotherapy Drugs: Two Drugs Harness Immune System To Fight Cancer - Huffington Post

"We've proposed a new set of response criteria to try to incorporate some of this biology." Yervoy, or ipilimumab, became the first drug ever to extend survival in patients with advanced melanoma, long seen as a short-term death sentence.

Researchers Identify New Treatment Approaches to Melanoma Brain Metastases - Newswise

For example, Ipilimumab, an immunotherapy, was approved by the FDA in March 2011 for the treatment of metastatic melanoma. Although initial studies excluded patients with active brain metastases, newer studies indicate that Ipilimumab is able to generate ...

New therapeutic options for management of melanoma brain metastases - News-Medical.Net

The effect on brain metastases of drugs such as Dabrafenib, Vemurafenib and Ipilimumab - which do not normally cross the blood-brain barrier - is likely reflective of a breakdown in the integrity of the blood-brain barrier as tumors grow ...

Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 - new market research report - Transworld News

The current treatment options for melanoma include: - Newly approved targeted therapies such as Yervoy(ipilimumab) and Zelboraf(vemurafenib) - Adjuvant therapies such as Intron-A (interferon alfa-2b) and Sylatron(peg-interferon alfa-2b) - Immunotherapy ...

Ireland's Eye: What's going on in the old sod this week - Irish Central

The Ashbourne father who last week made a desperate plea for the life-saving cancer drug Ipilimumab (Ipy) had his wish granted when Taoiseach (Prime Minister) Enda Kenny announced last Thursday that the drug would be made available to cancer ...

New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting - Yahoo Finance

The data further characterize the Company’s cancer immunotherapies, including YERVOY ® (ipilimumab) in metastatic melanoma, anti-PD-1 (BMS-936558) and elotuzumab, and support the potential role of immuno-oncology in the treatment of a range of cancers.

BioTrends tracks uptake of Yervoy and Zelboraf for advanced melanoma - News-Medical.Net

BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, has released findings from the second wave of its LaunchTrends ® Yervoy and Zelboraf report, in which 103 U.S.-based ...

Melanoma Agent Surprise: Brain Tumors Shrink Too - Medscape News

Gibney and Sondak. Some systemic therapies for melanoma, including ipilimumab, have demonstrated a positive but limited impact on brain metastases, as reported by Medscape Medical News. "Clearly, systemic agents of increased effectiveness are needed for ...